Work

Phase II Study of Biweekly Dose-Intense Paclitaxel Plus Gemcitabine (GEM/TAX) in Patients with Recurrent Locoregional or Metastatic Head and Neck Squamous Cell Carcinoma

Year: 2012

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1016/s0923-7534(20)33599-7

Authors: A. Sukari, M. Salem, M. Al-Hajeili, J. Jacobs, S. Taylo, G. Yoo, H. Lin, L. Heilbrun, A. Alousi, O. Kucuk

Institutions: Wayne State University, The Barbara Ann Karmanos Cancer Institute, The University of Texas MD Anderson Cancer Center, Emory University, Winship Cancer Institute

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2998850915

FWCI:

Cites:

Cited by:

Related to: 10